Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol

Naoto Katakami;  ; Tomoya Mita; Mitsuyoshi Takahara; Kiyoshi Hashigami; Masaru Kawashima; Iichiro Shimomura; Hirotaka Watada

doi:10.1007/s13300-017-0351-7

Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol

Diabetes Therapy ◽

10.1007/s13300-017-0351-7 ◽

2017 ◽

Vol 9 (1) ◽

pp. 165-175 ◽

Cited By ~ 7

Author(s):

Naoto Katakami ◽

◽

Tomoya Mita ◽

Mitsuyoshi Takahara ◽

Kiyoshi Hashigami ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Real World Setting ◽

Treatment Reality

Download Full-text

Abstract #288 Efficacy of Canagliflozin 300 Mg in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real World Setting

Endocrine Practice ◽

10.1016/s1530-891x(20)47133-2 ◽

2018 ◽

Vol 24 ◽

pp. 76-77

Author(s):

Pankaj Aneja ◽

Kunal Aneja ◽

Gaurav Bhalla ◽

Navneet Wadhwa

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real World ◽

Real World Setting

Download Full-text

Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting

Diabetes ◽

10.2337/db18-135-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 135-OR

Author(s):

WILLIAM T. CEFALU ◽

TAMARA DARSOW ◽

MATT PETERSEN ◽

LIISA PALMER ◽

ELLEN THIEL ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Treatment Persistence ◽

Real World Setting

Download Full-text

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter

Download Full-text

2220-PUB: Renal Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus in a Real-World Setting: The Renal-WECAN Study

Diabetes ◽

10.2337/db20-2220-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2220-PUB

Author(s):

JUAN J. GORGOJO-MARTINEZ ◽

MANUEL A. GARGALLO-FERNANDEZ ◽

ALBA GALDON ◽

TERESA ANTÓN-BRAVO ◽

MIGUEL BRITO-SANFIEL ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real World ◽

Sglt2 Inhibitor ◽

Inhibitor Therapy ◽

Renal Outcomes ◽

Real World Setting

Download Full-text

Assessment of Race-Specific Tolerability And Effectiveness of Exenatide once-Weekly or Basal Insulin Among Patients With Type 2 Diabetes In A Real World Setting In The USA

Value in Health ◽

10.1016/j.jval.2016.09.1845 ◽

2016 ◽

Vol 19 (7) ◽

pp. A667

Author(s):

JD Seeger ◽

AP Nunes ◽

AM Loughlin ◽

Q Qiao ◽

S Ezzy ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Basal Insulin ◽

Real World Setting ◽

The Usa

Download Full-text

Abstract #1004035: Efficacy and Safety of Remogliflozin in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real-world Setting

Endocrine Practice ◽

10.1016/j.eprac.2021.04.596 ◽

2021 ◽

Vol 27 (6) ◽

pp. S60

Author(s):

Ajay Sinha

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real World ◽

Efficacy And Safety ◽

Real World Setting

Download Full-text

Decision letter for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text

Review for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v1/review5 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text

Review for "Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin‐Naïve Patients with Type 2 Diabetes after Failure of Oral Therapy in a Real World Setting"

10.1111/dom.13952/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Oral Therapy ◽

Real World Setting

Download Full-text

Review for "How many people with type 2 diabetes fulfil eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?"

10.1111/dom.14264/v1/review3 ◽

2020 ◽

Author(s):

Luigi Meneghini

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Real World ◽

Controlled Trials ◽

Eligibility Criteria ◽

Randomized Controlled ◽

Real World Setting

Download Full-text